ArticleJournal of cellular and molecular medicine2020

The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations.

Ellen Weisberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.